Company Profile
SCL Science produces medical hemostatic agents using biomimetic technology. Its products include BiMM (Bio-inspired Medical Materials) that reacts immediately with blood. Its portfolio also includes Endoseal, which is used for specialized indication of gastrointestinal bleeding, InnoSeal, a hemostatic agent that is used in various surgical fields, such as cardiology, radiology, and neurosurgery, Jelly Seal, a hemostasis and sealing products, STOP, a non-bleeding intravascular injection, Film that prevents leakage at intestinal and vascular anastomosis sites, InnoLOCK and InTro vascular interventional procedure items, and operates bio-logistics business, as well as conducting clinical trial analysis services related to new drug development, in vitro diagnostic medical device performance evaluation, transportation of pharmaceuticals and clinical trial samples, etc. Founded in 2010 and headquartered in Seoul, South Korea, SCL Science was formerly known as InnoTherapy, Inc. before rebranding in March 2024.